CASE STUDY

Deferred Prosecution, Corporate Integrity and System
Improvement Agreements

Saranac is a thought leader on the negotiation and successful implementation of Deferred Prosecution, Corporate Integrity and Systems Improvement Agreements. Our clients have included managed care organizations, medical device manufacturers and healthcare providers.

The firm has advised a leading global biotechnology company, a high-profile provider of kidney dialysis services and a growth stage hospitalist staffing company on the negotiation and implementation of Corporate Integrity Agreements (CIAs) with the Office of Inspector General, U.S. Department of Health and Human Services. In each case, Saranac has worked closely with the Chief Compliance Officer, the in-house compliance and legal teams, and the client’s outside counsel. 

Boards of directors have also retained Saranac to serve as the "Outside Compliance Expert” referenced in many CIAs. In that role, the firm has provided boards, and board committees, with in-depth training and related materials regarding their oversight responsibilities in the areas of compliance, ethics and quality of care; assisted boards in developing operational protocols that are informed by best practices; advised boards on the information and reports that should be received from management; and led the periodic compliance program effectiveness review that CIAs often require.